New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues
MYGN focuses on effective capital deployment in key areas, including new tech-enabled tools and capabilities, innovation and commercial capabilities.
| Ticker |
Sentiment |
Impact |
|
QGEN
|
Neutral
|
5 %
|
|
TMDX
|
Neutral
|
18 %
|
|
ISRG
|
Neutral
|
13 %
|
|
BSX
|
Somewhat Bullish
|
22 %
|
|
MYGN
|
Somewhat Bullish
|
39 %
|
|
FOREX:USD
|
Neutral
|
13 %
|
